Effect of 4-trifluoromethyl derivatives of salicylate on nuclear factor κB-dependent transcription in human astrocytoma cells

British Journal of Pharmacology

Volumn 132, Issue 2, 2001, Pages 547-555

  Hernández, Marita ^a   Arriba, Alberto Fernández De ^b   Merlos, Manel ^b   Fuentes, Lucía ^a   Crespo, Mariano Sánchez ^a   Nieto, María Luisa ^c  

^a Universidad de Valladolid y Consejo Superior de Investigaciones Científicas   (Spain)

^b Laboratorio Uriach   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Adhesion molecules; Alzheimer disease; Aspirin; Astrocytes; Cyclo oxygenase; Gliosis; Inflammation; Nuclear factor B; Triflusal; Tumour necrosis factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SALICYLIC ACID; TRIFLUSAL; TUMOR NECROSIS FACTOR;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTOMA CELL; CELL LYSATE; DERIVATIZATION; DRUG EFFECT; ELECTROPHORETIC MOBILITY; ENHANCER REGION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATORY CELL; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0035126395     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703820     Document Type: Article

References (46)

1. Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IκB phosphorylation and NF-κB activation
2. Stimulation of FcγR receptors induces monocyte chemoattractant protein-1 (MCP-1) in the human monocytic cell line THP-1 by a mechanism involving IκBα degradation and formation of p50/p65 NF-κB/Rel complexe
3. Structure of the human cyclooxygenase-2 gene
4. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis
5. Stimulation of Fcγ receptors in rat peritoneal macrophages induces the expression of nitric oxide synthase and chemokines by mechanisms showing different sensitivities to antioxidants and nitric oxide donors
6. 4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor κB activation
7. Antiinflammatory effects of glucocorticoids in brain cells, independent of NF-κB
8. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
9. Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFκB
10. Triflusal versus aspirin on the inhibition of human platelet and blood cycooxygenase
11. Sodium salicylate and 17β-estradiol attenuate nuclear transcription factor NF-κB translocation in cultured rat astroglial cultures following exposure to amyloid Aβ (1-40) and lipopolysaccharides
12. Salicylate is a transcriptional inhibitor of the inducible nitric oxide synthase in cultured cardiac fibroblasts
13. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid
14. Indomethacin and aspirin abolish prostaglandin release from the spleen
15. Differential effects of lipopolysaccharide and tumor necrosis factor on monocytic IκB kinase signalsome activation and IκB proteolysis
16. Role of NF-κB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-α in human hepatic stellate cells. Involvement of cyclooxygenase-2
17. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation
18. 2 by a MEK-independent mechanism in the human astrocytoma cell line 1321N1
19. 2 and transactivation of cyclooxygenase-2
20. 2 in the human astrocytoma cell line 1321N1
21. Human cyclooxygenase-2 cDNA
22. Analgesic-antipyretics and antiinflammatory agents: Drugs employed in the treatment of rheumatoid arthritis and gout
23. Inhibition of NF-κB by sodium salicylate and aspirin
24. Inhibition of nuclear factor κB and induction of apoptosis in T-lymphocytes by sulfasalazine
25. Triflusal
26. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells
27. Sodium salicylate inhibits cyclooxygenase activity independently of transcription factor (nuclear factor-κB) activation: Role of arachidonic acid
28. Activation of NF-κB and induction of VCAM-1 and ICAM-1 expression in human glial cells by IL-1
29. Differential IκB kinase activation and IκBα degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells
30. Role of IKK1 and IKK2 in lipopolysaccharide signalling in human monocytic cells
31. Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells
32. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes
33. Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase mediation through different signaling pathways
34. Salicylates inhibit IκBα phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration
35. Triflusal. Platelet aggregation inhibitor
36. Pharmacokinetics of triflusal and its main metabolite in rats and dogs
37. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression
38. The anti-inflammatory drug sodium salicylate inhibits nitric oxide formation induced by interleukin-1β at a translational step, but not at a transcriptional step, in hepatocytes
39. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids
40. Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate
41. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
42. Sulfasalazine: A potent and specific inhibitor of nuclear factor κB
43. Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells
44. A proteasome inhibitor, an antioxidant, or a salicylate, but not a glucocorticoid, blocks constitutive and cytokine-inducible expression of P-selectin in human endothelial cells
45. Sulindac inhibits activation of the NF-κB pathway
46. The antiinflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β